Efficacy and safety of curative hepatectomy after conversion therapies for initial unresectable hepatocellular carcinoma: A multicenter propensity score matching study

被引:0
|
作者
Mai, R-Y. [1 ]
Guo, L. [2 ]
Liang, R. [3 ]
Wang, X-B. [1 ]
Bai, T. [1 ]
Chen, J. [1 ]
Lin, Z. [1 ]
Lin, Y. [3 ]
Wu, G. [1 ]
Xiang, B-D. [1 ]
Ma, L. [1 ]
Wu, F-X. [1 ]
Li, L-Q. [1 ]
Guo, W-X. [2 ]
Ye, J. [1 ]
机构
[1] Guangxi Med Univ, Dept Hepatobiliary & Pancreat Surg, Affiliated Tumor Hosp, Nanning, Peoples R China
[2] Second Mil Med Univ, Dept Hepat Suegery 6, Shanghai, Peoples R China
[3] Guangxi Med Univ, Dept Digest Oncol, Affiliated Tumor Hosp, Nanning, Peoples R China
基金
中国国家自然科学基金;
关键词
D O I
10.1016/j.annonc.2023.09.2142
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
998P
引用
收藏
页码:S612 / S613
页数:2
相关论文
共 50 条
  • [31] Geriatric nutritional risk index predicts prognosis in hepatocellular carcinoma after hepatectomy: a propensity score matching analysis
    Kanno, Hiroki
    Goto, Yuichi
    Sasaki, Shin
    Fukutomi, Shogo
    Hisaka, Toru
    Fujita, Fumihiko
    Akagi, Yoshito
    Okuda, Koji
    SCIENTIFIC REPORTS, 2021, 11 (01) : 9038
  • [32] No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis
    Peng, T.
    Zhao, G.
    Wang, L.
    Wu, J.
    Cui, H.
    Liang, Y.
    Zhou, R.
    Liu, Z.
    Wang, Q.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (06): : 719 - 728
  • [33] No impact of perioperative blood transfusion on prognosis after curative resection for hepatocellular carcinoma: a propensity score matching analysis
    T. Peng
    G. Zhao
    L. Wang
    J. Wu
    H. Cui
    Y. Liang
    R. Zhou
    Z. Liu
    Q. Wang
    Clinical and Translational Oncology, 2018, 20 : 719 - 728
  • [34] Safety and Efficacy of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma (3–5 cm): a Propensity Score Matching Cohort Study
    Qing-wang Ye
    Shu-jie Pang
    Ning Yang
    Hai-bin Zhang
    Yong Fu
    Bin Lin
    Guang-shun Yang
    Journal of Gastrointestinal Surgery, 2019, 23 : 1549 - 1558
  • [35] Efficacy and safety of neoadjuvant therapy in narrow-margin hepatocellular carcinoma: a propensity score matching analysis
    Li, Hongxuan
    Ren, Qiuyang
    Qi, Pan
    Shu, Bin
    Wang, Xiaojuan
    Zhu, Xiaoying
    Li, Gong
    Zhang, Yuewei
    Yang, Shizhong
    JOURNAL OF HEPATOLOGY, 2024, 80 : S442 - S442
  • [36] The clinical efficacy and safety of TACE combined with apatinib for advanced hepatocellular carcinoma: A propensity score matching analysis
    Chen, Cheng
    Duan, Xiaoting
    Shen, Yanfeng
    Li, Guiying
    INDIAN JOURNAL OF CANCER, 2024, 61 (02) : 390 - 395
  • [37] ANTIMICROBIAL PROPHYLAXIS AFTER HEPATIC RESECTION FOR HEPATOCELLULAR CARCINOMA: A PROPENSITY SCORE MATCHING STUDY
    Chen, Zebin
    Chen, Shuling
    Liang, Ruiming
    Peng, Zhenwei
    Peng, Sui
    GUT, 2019, 68 : A148 - A148
  • [38] Efficacy and Safety of Transarterial Chemoembolization Plus Lenvatinib with or Without Tislelizumab as the First-Line Treatment for Unresectable Hepatocellular Carcinoma: A Propensity Score Matching Analysis
    Jiang, Jiayun
    Zhang, Hui
    Lai, Jiejuan
    Zhang, Shiyu
    Ou, Yanjiao
    Fu, Yu
    Zhang, Leida
    JOURNAL OF HEPATOCELLULAR CARCINOMA, 2024, 11 : 1607 - 1622
  • [39] Sorafenib in combination with transarterial chemoembolization improves the survival of patients with unresectable hepatocellular carcinoma: A propensity score matching study
    Bai, Wei
    Wang, Yong Ji
    Zhao, Yan
    Qi, Xing Shun
    Yin, Zhan Xin
    He, Chuang Ye
    Li, Rui Jun
    Wu, Kai Chun
    Xia, Jie Lai
    Fan, Dai Ming
    Han, Guo Hong
    JOURNAL OF DIGESTIVE DISEASES, 2013, 14 (04) : 181 - 190
  • [40] Efficacy and safety of HAIC combined with tyrosine kinase inhibitors versus HAIC monotherapy for advanced hepatocellular carcinoma: a multicenter propensity score matching analysis
    Yang, Miaomiao
    Jiang, Xiongying
    Liu, Huan
    Zhang, Qingyu
    Li, Jing
    Shao, Li
    Zhao, Lei
    FRONTIERS IN PHARMACOLOGY, 2024, 15